[Multicentric clinical trial of a new combination of a broad spectrum antimycotic and a dermocorticoid (author's transl)]. 1979

R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet

After having reviewed the conditions of use of an antimycotic-corticoid combination, the authors are reporting their clinical results on 183 patients of a new drug combining econazole and triamcinolon. This clinical trial demonstrates that the own activity of each component of the combination is entirely maintained, and that the new combination shows an original interest in the treatment of all inflammatory dermatomycoses, as well as inflammatory supra-infected dermatoses.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007223 Infant A child between 1 and 23 months of age. Infants
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003881 Dermatomycoses Superficial infections of the skin or its appendages by any of various fungi. Skin Diseases, Fungal,Dermatomycosis,Dermatophyte Infection,Fungal Skin Diseases
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004464 Econazole An imidazole derivative that is commonly used as a topical antifungal agent. Econazole Nitrate,Ekonazole,Gyno-Pervaryl 150,Gyno-Pevaril,Gyno-Pevaryl,Pevaryl,Gyno Pervaryl 150,Gyno Pevaril,Gyno Pevaryl,GynoPevaril,Nitrate, Econazole
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet
December 1974, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet
September 1980, Zeitschrift fur Hautkrankheiten,
R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet
September 1974, Zeitschrift fur Hautkrankheiten,
R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet
March 1972, Die Medizinische Welt,
R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet
January 1979, Arzneimittel-Forschung,
R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet
December 1973, Deutsche medizinische Wochenschrift (1946),
R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet
November 1973, Munchener medizinische Wochenschrift (1950),
R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet
January 1979, Arzneimittel-Forschung,
R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet
January 1976, Arzneimittel-Forschung,
R Baran, and J Beurey, and J Civatte, and F Desmons, and M Hincky, and J Meynadier, and G Moulin, and Y Privat, and J Thivolet
May 1979, Experientia,
Copied contents to your clipboard!